Though the impact of JUN on the survival of lung cancers remains vague, a study on lung adenocarcinoma cell line (HCC827) showed that increased JUN expression was associated with gefitinib resistance in NSCLC and might lead to a poor prognosis [69]. The gene discussed is JUN; the disease is lung carcinoma.